32 Stocks Moving In Wednesday's Mid-Day Session

Loading...
Loading...

Gainers

  • CounterPath, Corp. CPAH shares jumped 110.8 percent to $4.68 following Q2 results. CounterPath reported Q2 earnings of $0.01 per share on revenue of $3.4 million.
  • Apollo Medical Holdings, Inc. AMEH shares climbed 46.4 percent to $23.4373.
  • Digital Power Corporation DPW shares jumped 34.6 percent to $5.53. Digital Power reported a cryptocurrency mining division.
  • Finisar Corporation FNSR jumped 26.5 percent to $24.41 following announcement of a $390 million award from Apple Inc. AAPL.
  • Wins Finance Holdings Inc WINS shares gained 25 percent to $64.06.
  • Streamline Health Solutions Inc. STRM climbed 19.4 percent to $1.61 after the company reported strong results for its third quarter on Tuesday.
  • Cellectis SA (ADR) CLLS surged 14 percent to $27.38 as the company announced preliminary data yesterday from Servier and Pfizer's UCART19 product candidate showing high complete remission rate across 2 acute lymphoblastic leukemia trials.
  • Sphere 3D Corp ANY climbed 13.2 percent to $2.15 after tumbling 18.38 percent on Tuesday.
  • CHF Solutions Inc CHFS gained 11.5 percent to $3.99 after the company reported a distribution agreement with TRANSMEDIC to market CHF's Aquadex FlexFlow in Singapore.
  • Capricor Therapeutics Inc CAPR rose 10.6 percent to $1.77 as the company disclosed that it has been issued a patent for Exosome technology.
  • Marathon Patent Group Inc MARA shares climbed 9.5 percent to $6.35.
  • Amplify Snack Brands Inc BETR shares gained 9 percent to $6.97.
  • NXT-ID Inc NXTD shares rose 8.6 percent to $1.28 following speculation that the stock could be a play on Bitcoin/Crypto.
  • Arcimoto Inc FUV shares gained 8.2 percent to $4.26.
  • Extended Stay America Inc STAY rose 4.3 percent to $17.94. JP Morgan upgraded Extended Stay America from Neutral to Overweight.


Losers

  • Helios and Matheson Analytics Inc HMNY dipped 34.4 percent to $6.61 after the company reported a common stock offering. The size of the offering was not disclosed. The company said that proceeds from the offering and warrants will be used to increase the company’s ownership stake in MoviePass.
  • Nordic American Tanker Ltd NAT shares tumbled 26.2 percent to $2.71 after announcing a $100 million common stock offering.
  • Riot Blockchain Inc RIOT shares declined 13.1 percent to $24.50 after surging 22.18 percent on Tuesday.
  • Bristow Group Inc BRS shares fell 12.4 percent to $12.63.
  • ArcBest Corp ARCB shares dropped 11.8 percent to $34.00. Stifel Nicolaus downgraded ArcBest from Hold to Sell.
  • Tel-Instrument Electronics Corp. TIK shares fell 11.6 percent to $3.05 after climbing 52.17 percent on Tuesday.
  • Civitas Solutions Inc CIVI shares slipped 10.9 percent to $17.65. Civitas Solutions posted Q4 loss of $10.7 million on sales of $380.372 million.
  • Lumentum Holdings Inc LITE shares dropped 9.9 percent to $46.63 after dipping 3.27 percent on Tuesday.
  • Proteostasis Therapeutics Inc PTI shares dropped 9.8 percent to $5.54 after the company announced a 7 million-share common stock offering.
  • Intellia Therapeutics Inc NTLA shares declined 9.8 percent to $16.54 after dropping 4.41 percent on Tuesday.
  • Net Element Inc NETE shares jumped 7.7 percent to $5.73.
  • Genomic Health, Inc. GHDX shares fell 8.3 percent to $27.55. JP Morgan downgraded Genomic Health from Neutral to Underweight.
  • Arrowhead Pharmaceuticals Inc ARWR dropped 7.8 percent to $3.27. The company reported a FY17 EPS loss of 47 cents, down from a loss of $1.34 in the same quarter last year. Sales came in at over $31 million.
  • Mongodb Inc MDB slipped 6.8 percent to $27.03 after reporting a loss of 44 cents in the third quarter on sales of over $4 million. However, the company issued fourth quarter and FY18 earnings guidance below consensus.
  • Accuray Incorporated ARAY declined 5.5 percent to $4.78. JP Morgan downgraded Accuray from Neutral to Underweight.
  • VeriFone Systems Inc PAY dropped 4.8 percent to $17.60. VeriFone reported better-than-expected results for its fourth quarter. The company issued weak first quarter and FY18 guidance. The company also announced a $100 million buyback plan.
  • bluebird bio Inc BLUE shares slipped 4.4 percent to $182.60. bluebird bio priced its 3.2 million share offering at $185 per share. Maxim Group downgraded bluebird bio from Buy to Hold.
Loading...
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversMid-Day LosersMid-Day MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...